Lv1
60 积分 2025-07-17 加入
Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non–Small Cell Lung Cancer
2天前
已完结
Coffee and Tea Intake, Dementia Risk, and Cognitive Function
4天前
已完结
FGFR rearrangements: oncogenic drivers and therapeutic targets
6天前
已关闭
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
16天前
已完结
Head and Neck Cancer
1个月前
已完结
TROP-2–directed antibody–drug conjugates in advanced NSCLC: A systematic review and meta-analysis of efficacy, safety, and reconstructed survival outcomes
1个月前
已完结
EGFR -mutated non-small cell lung cancer
1个月前
已完结
Targeting common EGFR mutations in NSCLC—review of global phase III trials of third-generation inhibitors
1个月前
已完结
Sacituzumab tirumotecan improves OS in EGFR TKI-resistant NSCLC
1个月前
已完结
Expanding targeted therapy for lung cancer
1个月前
已完结
皖公网安备34019202002308
